BPG is committed to discovery and dissemination of knowledge
Observational Study
Copyright: ©Author(s) 2026.
World J Crit Care Med. Jun 9, 2026; 15(2): 118803
Published online Jun 9, 2026. doi: 10.5492/wjccm.v15.i2.118803
Table 2 Univariate analysis for in-hospital mortality
Variable
Survivors (n = 60)
Non-survivors (n = 8)
P value
Age (years)54 (39-61)45 (26-60)0.319
Hospital stay (days)9 (6-13)6 (4-9)0.192
FiO2 on admission (%)32 (21-53)55 (25-67)0.099
Hemoglobin on admission (g/dL)10.9 ± 1.89.6 ± 4.10.115
Serum creatinine on admission (mg/dL)1.35 (0.9-2.9)1.28 (0.6-5.7)0.165
APACHE-II on admission15.1 ± 7.419.1 ± 10.60.176
SOFA score on admission8.7 ± 3.88.5 ± 4.30.919
Bleeding5 (7.4)3 (37.5)0.016
NIV use during ICU stay6 (10.0)3 (37.5)0.031
Blood product transfusion6 (10.0)4 (50.0)0.003
Dengue infection13 (21.7)5 (62.5)0.014
AKI stage ≥ 2 on admission25 (41.7)4 (50.0)0.848
Dialysis requirement16 (26.7)3 (37.5)0.521
Renal non-recovery at discharge2 (3.3)8 (100)< 0.001
Invasive ventilation24 (40.0)3 (37.5)0.892
Vasopressor use26 (43.3)2 (25.0)0.322


Write to the Help Desk